Efficacy and Safety of Lenvatinib Plus Pembrolizumab Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma
The purpose of this study is to assess the efficacy and safety of lenvatinib (E7080/MK-7902) plus pembrolizumab (MK-3475) plus chemotherapy compared with chemotherapy alone in participants with advanced/metastatic gastroesophageal cancer. The